tradingkey.logo
tradingkey.logo

Australia's CSL to supply vaccines to Canada in case of flu pandemic; shares jump

ReutersMar 5, 2026 4:45 AM

Shares of CSL CSL.AX rise as much as 3.5% to A$147.90, their highest level since February 24

Co's vaccine business, CSL Seqirus, wins contract to support influenza pandemic preparedness plans of the Canadian government, per Australia-Canada joint statement

CSL Seqirus' advanced cell-based vaccine manufacturing facility in Australia to supply Canada with 15 million vaccines in the event of a pandemic

Stock down 15% this year, including the day's move

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI